Published in Cell Stem Cell on January 02, 2014
Stem cell imaging: from bench to bedside. Cell Stem Cell (2014) 1.49
The immune response of stem cells in subretinal transplantation. Stem Cell Res Ther (2015) 1.05
Stem cell-based therapies for cancer treatment: separating hope from hype. Nat Rev Cancer (2014) 0.96
The immunogenicity of cells derived from induced pluripotent stem cells. Cell Mol Immunol (2013) 0.86
Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev (2015) 0.83
Advances in β cell replacement and regeneration strategies for treating diabetes. J Clin Invest (2016) 0.82
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. Oncogene (2015) 0.81
Biomaterial Approaches for Stem Cell-Based Myocardial Tissue Engineering. Biomark Insights (2015) 0.80
Potential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells. J Comp Neurol (2014) 0.80
Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors. Mol Ther (2016) 0.79
Humanized Mouse Models for Transplant Immunology. Am J Transplant (2015) 0.78
Functional disruption of human leukocyte antigen II in human embryonic stem cell. Biol Res (2015) 0.77
Modeling Kidney Disease with iPS Cells. Biomark Insights (2015) 0.76
Gene Targeting Through Homologous Recombination in Monkey Embryonic Stem Cells Using CRISPR/Cas9 System. Stem Cells Dev (2015) 0.76
ESCaping rejection: A step forward for embryonic-stem-cell-based regenerative medicine. Cell Stem Cell (2014) 0.75
Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation. Transplant Rev (Orlando) (2016) 0.75
May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells. Cells (2017) 0.75
Proceedings: Immune Tolerance and Stem Cell Transplantation: A CIRM Mini-Symposium and Workshop Report. Stem Cells Transl Med (2014) 0.75
Humanized mouse model for assessing the human immune response to xenogeneic and allogeneic decellularized biomaterials. Biomaterials (2017) 0.75
Molecular imaging of stem cells for the treatment of acute myocardial infarction. Int J Clin Exp Med (2015) 0.75
Economic 3D-printing approach for transplantation of human stem cell-derived β-like cells. Biofabrication (2016) 0.75
The Tumorigenicity of Multipotent Adult Germline Stem Cells Transplanted into the Heart Is Affected by Natural Killer Cells and by Cyclosporine A Independent of Its Immunosuppressive Effects. Front Immunol (2017) 0.75
Comparative global immune-related gene profiling of somatic cells, human pluripotent stem cells and their derivatives: implication for human lymphocyte proliferation. Exp Mol Med (2017) 0.75
The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives. Front Immunol (2017) 0.75
Immunological Issues After Stem Cell-Based β Cell Replacement. Curr Diab Rep (2017) 0.75
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol (2008) 19.24
Of mice and not men: differences between mouse and human immunology. J Immunol (2004) 10.61
Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet (2012) 7.70
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Immunogenicity of induced pluripotent stem cells. Nature (2011) 7.31
The PD-1 pathway in tolerance and autoimmunity. Immunol Rev (2010) 5.99
Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A (2012) 4.85
Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood (2004) 4.32
The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol (2002) 3.47
Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol (2012) 3.41
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev (2008) 3.18
Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood (2006) 2.94
SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol (2011) 2.84
Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell (2008) 2.74
Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci U S A (2011) 2.41
Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell (2010) 2.19
Regulatory immune cells in transplantation. Nat Rev Immunol (2012) 1.82
Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells (2003) 1.75
Turning straw into gold: directing cell fate for regenerative medicine. Nat Rev Genet (2011) 1.73
Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol (2013) 1.70
Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood (2008) 1.60
Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med (2005) 1.53
Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol (2010) 1.45
Species differences in the structure and function of the immune system. Toxicology (2003) 1.30
A model for personalized in vivo analysis of human immune responsiveness. Sci Transl Med (2012) 1.27
Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines. Stem Cells (2011) 1.26
Prodrug-activating systems in suicide gene therapy. J Clin Invest (2000) 1.21
Protecting against wayward human induced pluripotent stem cells with a suicide gene. Biomaterials (2012) 1.20
Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy (2008) 1.07
Shuttle of lentiviral vectors via transplanted cells in vivo. Gene Ther (2005) 1.02
Mouse models with human immunity and their application in biomedical research. J Cell Mol Med (2008) 0.99
Concise review: Immune recognition of induced pluripotent stem cells. Stem Cells (2012) 0.98
A scalable approach to prevent teratoma formation of human embryonic stem cells. J Biol Chem (2012) 0.97
Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs. Exp Hematol (2006) 0.95
Belatacept: from rational design to clinical application. Transpl Int (2011) 0.93
Natural killer cells and the immune response in solid organ transplantation. Am J Transplant (2010) 0.93
The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials. Transpl Immunol (2004) 0.92
Response to Frederic Bretzner et al. "Target populations for first-in-human embryonic stem cell research in spinal cord injury". Cell Stem Cell (2011) 0.91
Self-renewal and scalability of human embryonic stem cells for human therapy. Regen Med (2011) 0.87
Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy. J Immunol (2007) 0.83
The immunosuppressive pipeline: meeting unmet needs in liver transplantation. Liver Transpl (2010) 0.80
Donor bone marrow infusions are tolerogenic in human renal transplantation. Transplant Proc (2001) 0.78